Article Text

PDF

Androgen associated hepatocellular carcinoma with an aggressive course.
  1. D Gleeson,
  2. M J Newbould,
  3. P Taylor,
  4. R F McMahon,
  5. B C Leahy,
  6. T W Warnes
  1. Department of Gastroenterology, Royal Infirmary, Manchester.

    Abstract

    The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.